These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34621493)

  • 1. Patients' time in therapeutic range on warfarin among atrial fibrillation patients in Warfarin Medication Therapy Adherence Clinic.
    Lee SL; Ong TJ; Mazlan-Kepli W; Mageswaran A; Tan KH; Abd-Malek AM; Cronshaw R
    World J Cardiol; 2021 Sep; 13(9):483-492. PubMed ID: 34621493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study.
    Ng DL; Malik NMBA; Chai CS; Goh GM; Tan SB; Bee PC; Gan GG; Said AB
    Health Qual Life Outcomes; 2020 Oct; 18(1):347. PubMed ID: 33081816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohort.
    Liu S; Singer A; McAlister FA; Peeler W; Heran BS; Drummond N; Manca DP; Allan GM; Korownyk C; Kolber MR; Greiver M; Garrison SR
    Can Fam Physician; 2019 Jun; 65(6):416-425. PubMed ID: 31189630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Standardized Warfarin Treatment Protocol on Anticoagulant Effect: Comparison of a Warfarin Medication Therapy Adherence Clinic with Usual Medical Care.
    Aidit S; Soh YC; Yap CS; Khan TM; Neoh CF; Shaharuddin S; Kassab YW; Patel RP; Ming LC
    Front Pharmacol; 2017; 8():637. PubMed ID: 29170637
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation.
    Vinding NE; Bonde AN; Rørth R; Lamberts M; Olesen JB; Gislason GH; Torp-Pedersen C; Køber L; Fosbøl EL
    Europace; 2019 Apr; 21(4):572-580. PubMed ID: 30508073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin.
    Marcatto LR; Sacilotto L; Tavares LC; Facin M; Olivetti N; Strunz CMC; Darrieux FCC; Scanavacca MI; Krieger JE; Pereira AC; Santos PCJL
    Front Pharmacol; 2018; 9():1052. PubMed ID: 30298004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
    Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HAS-BLED Predicts Warfarin Control in Australian Patients treated for Deep Vein Thrombosis.
    Mueller K; Bernaitis N; Badrick T; Anoopkumar-Dukie S
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):299-302. PubMed ID: 27718518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of warfarin control in atrial fibrillation patients in South East Queensland, Australia.
    Bernaitis N; Badrick T; Davey AK; Anoopkumar-Dukie S
    Intern Med J; 2016 Aug; 46(8):925-31. PubMed ID: 27040159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of anticoagulant control and patient experience associated with long-term warfarin in Canadian patients with non-valvular atrial fibrillation: A multicentre, prospective study.
    Selby R; Kaus L; Sealey F; Koo M; Parpia S; Chan B; Seung SJ; Bradley C; Strauss R; Mittmann N
    PLoS One; 2023; 18(4):e0284425. PubMed ID: 37071625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Time in Therapeutic Range (TTR) in Patients with Non-Valvular Atrial Fibrillation Receiving Treatment with Warfarin in Tehran, Iran: A Cross-Sectional Study.
    Farsad BF; Abbasinazari M; Dabagh A; Bakshandeh H
    J Clin Diagn Res; 2016 Sep; 10(9):FC04-FC06. PubMed ID: 27790456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time in therapeutic range values of patients using warfarin and factors that influence time in therapeutic range.
    Dinç Asarcıklı L; Kafes H; Şen T; Gucuk İpek E; Cebeci M; Gül M; Kanat S; Temizhan A
    Turk Kardiyol Dern Ars; 2021 Sep; 49(6):463-473. PubMed ID: 34523594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management.
    Bahbahani H; AlTurki A; Dawas A; Lipman ML
    BMC Nephrol; 2018 Jan; 19(1):4. PubMed ID: 29310600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score.
    Apostolakis S; Sullivan RM; Olshansky B; Lip GYH
    Chest; 2013 Nov; 144(5):1555-1563. PubMed ID: 23669885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.
    Pokorney SD; Simon DN; Thomas L; Fonarow GC; Kowey PR; Chang P; Singer DE; Ansell J; Blanco RG; Gersh B; Mahaffey KW; Hylek EM; Go AS; Piccini JP; Peterson ED;
    Am Heart J; 2015 Jul; 170(1):141-8, 148.e1. PubMed ID: 26093875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality control of oral anticoagulant therapy in Primary Care in Madrid City, Spain: CHRONOS-TAO study].
    Alonso Roca R; Figueroa Guerrero CA; Mainar de Paz V; Arribas García MP; Sánchez Perruca L; Rodríguez Barrientos R; Casado López M; Pedraza Flechas AM
    Med Clin (Barc); 2015 Sep; 145(5):192-7. PubMed ID: 25433789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor anticoagulation control in patients taking warfarin at a tertiary and district-level prothrombin clinic in Cape Town, South Africa.
    Ebrahim I; Bryer A; Cohen K; Mouton JP; Msemburi W; Blockman M
    S Afr Med J; 2018 May; 108(6):490-494. PubMed ID: 30004329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes associated with warfarin time in therapeutic range among US veterans with nonvalvular atrial fibrillation.
    Liu S; Li X; Shi Q; Hamilton M; Friend K; Zhao Y; Horblyuk R; Hede S; Shi L
    Curr Med Res Opin; 2018 Mar; 34(3):415-421. PubMed ID: 28945114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SAMe-TT2R2 score for prediction of suboptimal time in therapeutic range in a Thai population with atrial fibrillation.
    Krittayaphong R; Winijkul A; Pirapatdit A; Chiewvit P; Komoltri C; Boonyapisit W; Arunsiriwattana S; Bunyapipat T; Apiyasawat S; Rattanasumawong K; Yindeengam A;
    Singapore Med J; 2020 Dec; 61(12):641-646. PubMed ID: 31680175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.